SHL Telemedicine is a world leading provider of telemedicine services with over 25 years of experience for over million users. The company's innovative personal ECG technology and devices are at the front tier of technology. SHL’s latest innovation, the smartheart is the first & only personal and mobile 12 lead ECG device in the market, enabling the detection of ischemic cardiac events. With smartheart any person with a smartphone or tablet can perform a full hospital grade 12 lead ECG without the need for the assistance of a medical professional and send it to his physician/clinic/hospital for diagnosis. All of this within seconds. The smartheart as well as all other SHLs' devices is FDA cleared and bears the CE mark. In addition, smartheart provides a unique mHealth solution for the significant reduction in readmission rates of post heart attack (MI) patients, one of the most challenging burdens which all healthcare systems are faced with. SHL's telemedicine solutions are proven to materially reduce the burden of healthcare systems’ costs with regard to chronic patients (CHF, COPD etc) while improving quality of care and lifestyle of these patients. For more details, please visit our website at: www.shl-telemedicine.com